ToleroMune Ragweed Follow up Study

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Ragweed AllergyRhinoconjunctivitis
Interventions
BIOLOGICAL

Placebo

No further medication to be administered in this study. Intervention refers to treatment received in Study TR002.

BIOLOGICAL

ToleroMune Ragweed

No further medication to be administered in this study. Intervention refers to treatment received in Study TR002.

Trial Locations (1)

L4W 1N2

Cetero Research, Mississauga

All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

collaborator

Cetero Research, San Antonio

NETWORK

lead

Circassia Limited

INDUSTRY

NCT01448603 - ToleroMune Ragweed Follow up Study | Biotech Hunter | Biotech Hunter